Clearmind Medicine Inc. (CMND) income statement
CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Score 5/30
$3.04−0.02 (-0.82%)
Close on Nov 19, 2026Market cap $480.55KP/E –Yield –
Clearmind Medicine Inc. financial ratios
See a number that looks wrong?